Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Novavax | NVAX | Nov 25, 2024 | 9.32 | +10.04 |
Novo Integrated Sciences | NVOS | Nov 25, 2024 | 0.17 | 0.00 |
Novo Nordisk ADR | NVO | Nov 25, 2024 | 104.56 | -0.48 |
NovoCure | NVCR | Nov 25, 2024 | 18.78 | +5.92 |
Novonix ADR | NVX | Nov 25, 2024 | 2.69 | +39.38 |
NRG Energy | NRG | Nov 25, 2024 | 91.87 | -3.78 |
NRx Pharmaceuticals | NRXP | Nov 25, 2024 | 1.31 | +3.97 |
NSTS Bancorp | NSTS | Nov 25, 2024 | 11.11 | -1.16 |
Nu Holdings | NU | Nov 25, 2024 | 14.23 | +2.30 |
Nu Skin Enterprises | NUS | Nov 25, 2024 | 7.55 | +4.57 |
Nuburu | BURU | Nov 25, 2024 | 0.45 | -4.75 |
NuCana ADR | NCNA | Nov 25, 2024 | 1.26 | +2.44 |
Nucor | NUE | Nov 25, 2024 | 153.44 | +1.00 |
Nukkleus | NUKK | Nov 25, 2024 | 1.67 | -4.57 |
Nurix Therapeutics | NRIX | Nov 25, 2024 | 21.82 | -1.04 |
NuScale Power | SMR | Nov 25, 2024 | 28.06 | -7.12 |
Nustar Energy C Pref | NS-C | Nov 25, 2024 | 24.99 | 0.00 |
Nutanix A | NTNX | Nov 25, 2024 | 72.80 | -0.52 |
Nutex Health | NUTX | Nov 25, 2024 | 34.22 | +3.98 |
Nutriband | NTRB | Nov 25, 2024 | 4.75 | -1.25 |
Nutrien | NTR | Nov 25, 2024 | 46.80 | -0.28 |
Nuvalent A | NUVL | Nov 25, 2024 | 95.62 | +0.73 |
Nuvation Bio A | NUVB | Nov 25, 2024 | 2.89 | +3.21 |
Nuvectis Pharma | NVCT | Nov 25, 2024 | 4.95 | -2.94 |
Nuveen Amtfree Municipal Credit Income Fund | NVG | Nov 25, 2024 | 12.90 | +0.08 |
Nuveen Amtfree Municipal Value Fund | NUW | Nov 25, 2024 | 13.93 | +0.69 |
Nuveen Amtfree Quality Municipal Income Fund | NEA | Nov 25, 2024 | 11.67 | +0.43 |
Nuveen Arizona Quality Municipal Fund | NAZ | Nov 25, 2024 | 12.29 | +0.33 |
Nuveen California Amtfree Quality Municipal Income Fund | NKX | Nov 25, 2024 | 12.88 | -0.16 |
Nuveen California Municipal Value Fund | NCA | Nov 25, 2024 | 8.69 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.